Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,225
  • Shares Outstanding, K 130,994
  • Annual Sales, $ 1,230 K
  • Annual Income, $ -26,970 K
  • EBIT $ -23 M
  • EBITDA $ -22 M
  • 60-Month Beta 1.29
  • Price/Sales 16.71
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.22
  • Most Recent Earnings $-0.04 on 11/13/25
  • Next Earnings Date 03/30/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 686.59% (-598.61%)
  • Historical Volatility 99.26%
  • IV Percentile 91%
  • IV Rank 43.36%
  • IV High 1,285.20% on 02/04/26
  • IV Low 228.31% on 11/12/25
  • Expected Move (DTE 12) 1.8615 (756.71%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 12
  • Volume Avg (30-Day) 64
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 3,010
  • Open Int (30-Day) 2,546
  • Expected Range 0.0000 to 2.1075

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.06
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2400 +2.50%
on 02/06/26
0.3863 -36.32%
on 01/08/26
-0.0308 (-11.13%)
since 01/06/26
3-Month
0.2200 +11.82%
on 12/29/25
0.4316 -43.00%
on 11/07/25
-0.1660 (-40.29%)
since 11/06/25
52-Week
0.2200 +11.82%
on 12/29/25
0.9400 -73.83%
on 06/23/25
-0.3736 (-60.30%)
since 02/06/25

Most Recent Stories

More News
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation

  Showing New Indication for Nu.Q ® NETs 

VNRX : 0.2460 (-0.40%)
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

HENDERSON, Nev. , Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the preparation of the reimbursement submission...

VNRX : 0.2460 (-0.40%)
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

Nu.Q® Biomarker Paper Available on MedRXIV

VNRX : 0.2460 (-0.40%)
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

HENDERSON, Nev. , Jan. 20, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the appointment of two new centralized laboratory...

VNRX : 0.2460 (-0.40%)
Volition Sponsors Symposium at Veterinary Meeting and Expo

HENDERSON, Nev. , Jan. 16, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the sponsorship of an industry symposium at...

VNRX : 0.2460 (-0.40%)
VolitionRx Secures $2.0 Million in Funding

HENDERSON, Nev. , Jan. 8, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that it has entered into...

VNRX : 0.2460 (-0.40%)
VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

Paves the Way for World's First Feline Liquid Biopsy Test for Cancer Detection

VNRX : 0.2460 (-0.40%)
Volition Issues Business Review 2025

HENDERSON, Nev. , Dec. 17, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, issues a Business Review of 2025.

VNRX : 0.2460 (-0.40%)
Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment

HENDERSON, Nev. , Dec. 11, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces preprint availability of a new manuscript entitled...

VNRX : 0.2460 (-0.40%)
Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer

HENDERSON, Nev., , December 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of two abstracts at the...

VNRX : 0.2460 (-0.40%)

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

3rd Resistance Point 0.2732
2nd Resistance Point 0.2653
1st Resistance Point 0.2557
Last Price 0.2460
1st Support Level 0.2382
2nd Support Level 0.2303
3rd Support Level 0.2207

See More

52-Week High 0.9400
Fibonacci 61.8% 0.6650
Fibonacci 50% 0.5800
Fibonacci 38.2% 0.4950
Last Price 0.2460
52-Week Low 0.2200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar